Following the publication of a study linking vaping with an increased risk of COVID-19, U.S. lawmakers have urged the U.S. Food and Drug Administration (FDA) to remove vaping products from the market. Raja Krishnamoorthi, Chairman of the U.S. House of Representatives Subcommittee on Economic and…
Two Zantac lawsuits recently joined the consolidated litigation in the U.S. District Court for the Southern District of Florida. Both plaintiffs claim to have been seriously injured after taking Zantac (ranitidine) for extended periods. Kentucky Plaintiff Blames Zantac for Bladder Cancer The first plaintiff, from…
Soon after the U.S. Food and Drug Administration (FDA) approved the Nuvasive MAGEC System for the treatment of early-onset scoliosis (EOS), studies on the system revealed potential defects that could lead to injuries in children. In a 2017 study, for example, researchers reported that the…
Zantac (ranitidine) manufacturers Sanofi and GlaxoSmithKline (GSK) have recently come under investigation by the U.S. Department of Justice (DOJ) concerning their failure to disclose the presence of N-nitrosodimethylamine (NDMA), a cancer-causing agent, in the popular heartburn drug. According to Reuters, both companies received “civil investigation…
Two new plaintiffs have filed Elmiron lawsuits in Pennsylvania and New Jersey. Both claim that after using Elmiron to treat interstitial cystitis (IC), they suffered from vision damage. Plaintiffs Take Elmiron and Years Later, Suffer Vision Damage The first case was filed in May 2020…
A Texas man recently filed a new Uloric lawsuit in the U.S. District Court for the Northern District of Illinois. He claims that after taking the gout medication, he suffered from serious injuries. He seeks to hold manufacturer Takeda Pharmaceuticals liable for damages. In February…
Hundreds of new JUUL lawsuits have been filed in U.S. courts over the past year. These include individual claims in which plaintiffs blame JUUL’s advertising for misleading them about the addictive nature of the company’s e-cigarettes, as well as class-action claims filed on behalf of…
Due to a declining demand related to talc-based health risks, Johnson & Johnson (J&J) has stopped producing its Johnson’s Baby Powder in the U.S. The company maintains that its products are safe, however, and has appealed verdicts lost in talc-based lawsuits. One of those verdicts…
Under pressure from scientists and consumers, Janssen Pharmaceuticals has updated the label for its interstitial cystitis (IC) drug, Elmiron, to address the risk of developing damage to your vision. The company had already made similar label changes in Canada and Europe but failed to warn…
Interstitial cystitis (IC) drug Elmiron (pentosan polysulfate sodium or PPS) has been on the market since 1996. Recent studies have linked long-term use of this drug to an increased risk of a rare form of eye damage called pigmentary maculopathy. Individuals who used the product…
